首页> 外文OA文献 >Rapid Detection of the Mosaic Structure of the Neisseria gonorrhoeae penA Gene, Which Is Associated with Decreased Susceptibilities to Oral Cephalosporins▿
【2h】

Rapid Detection of the Mosaic Structure of the Neisseria gonorrhoeae penA Gene, Which Is Associated with Decreased Susceptibilities to Oral Cephalosporins▿

机译:快速检测淋病奈瑟氏球菌penA基因的镶嵌结构,该结构与对口服头孢菌素的敏感性降低有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In Neisseria gonorrhoeae, the mosaic structure of the penA gene (encoding penicillin-binding protein 2 [PBP 2]), which is composed of fragments of the penA genes from Neisseria cinerea and Neisseria perflava, has been significantly associated with decreased susceptibility to cephalosporins, particularly oral cephalosporins. The aim of this study was to develop a rapid assay for the detection of mosaic PBP 2 of N. gonorrhoeae by real-time PCR. This assay successfully detected the mosaic penA gene of N. gonorrhoeae, and its sensitivity was ≥101 copies/reaction. Six hundred twenty-one clinical strains were examined by this assay for the presence of mosaic PBP 2, which was detected in 85 (39.4%) of 216 strains from 2002, 69 (40.6%) of 170 strains from 2003, 71 (44.4%) of 160 strains from 2004, and 31 (41.3%) of 75 strains from 2005. The MICs of cephalosporins for strains with the mosaic PBP 2 detected by the assay were statistically higher than those for strains without the mosaic PBP 2. One hundred sixty-six (64.8%) of 256 strains with the mosaic PBP 2 exhibited cefixime MICs of ≥0.5 μg/ml. The emergence and spread of strains with mosaic PBP 2 could be a threat to the cefixime treatment of gonorrhea. This real-time PCR assay for the detection of mosaic PBP 2 of N. gonorrhoeae is thus useful in the prediction of decreased susceptibilities to oral cephalosporins.
机译:在淋病奈瑟氏球菌中,penA基因的编码结构(编码青霉素结合蛋白2 [PBP 2])由灰霉病奈瑟氏菌和perisslava奈瑟氏菌的penA基因片段组成,与头孢菌素的易感性明显降低有关,特别是口服头孢菌素。这项研究的目的是开发一种通过实时荧光定量PCR检测淋病奈瑟氏菌马赛克PBP 2的快速方法。该测定法成功地检测到淋病奈瑟氏球菌的镶嵌penA基因,其敏感性≥101拷贝/反应。通过此测定法检查了621个临床菌株中是否存在花叶PBP 2,在2002年的216株菌株中有85(39.4%)种,在2003年的170株菌株中有69(40.6%)种,在71(44.4%)中检测到)从2004年开始筛选160株菌株,从2005年开始从75株菌株中筛选31株(41.3%)。通过该分析检测到的具有镶嵌PBP 2菌株的头孢菌素的MICs高于没有镶嵌PBP 2菌株的头孢菌素的MIC。镶嵌PBP 2的256个菌株中有6个(64.8%)的头孢克辛MIC≥0.5μg/ ml。镶嵌PBP 2菌株的出现和传播可能对头孢克肟治疗淋病的威胁。因此,这种用于检测淋病奈瑟氏球菌马赛克PBP 2的实时PCR分析可用于预测对口服头孢菌素敏感性降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号